Several cytokines, including interleukins and interferons, and other mediators of inflammation were associated with both colon (INFGR1, IL6, IRF2, NFκB1A, TLR2) and rectal cancer survival (IL1A and IL3), as was suppressor of cytokine signaling (SOCS1). Here, IRF2 is linked to rectal cancer.